ACER-001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ACER-001, covering 2025-07-11 to 2025-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) [Phase 2]